N-4-piperidinyl compounds as ccr5 modulators
OwnerJeremy Burrows, John Cumming +1inventors
InventorsJeremy Burrows, John Cumming, Howard Tucker
Life of this patent
Estimating the term…
Abstract
The invention provides a compound of formula (1): wherein R1, R2, R3, R3a, R4, R4a, R5, and R6 are defined; or a pharmaceutically acceptable salt thereof or a solvate thereof; compositions containing these compounds, processes for preparing them and their use as modulators of chemokine activity (especially CCR5 activity).
Claims13
A compound of formula (I):
- 40
- wherein:
- R1 is C3-7 cycloalkyl, C4-7 cycloalkyl fused to a phenyl ring, C5-7 cycloalkenyl, heterocyclyl (itself optionally substituted by oxo or C1-4 alkyl), C1-8 alkyl (substituted by C3-6 cycloalkyl, C5-6 cycloalkenyl, S(O)pR7 or COR8), C2-8 alkenyl or C2-8 alkynyl;
- R2 is optionally substituted phenyl, optionally substituted heteroaryl or cycloalkyl;
- R2a, R4 and R4a are, independently, hydrogen or C1-4 alkyl;
- R3 and R3a are, independently, hydrogen or C1-4 alkyl or C1-4 alkoxy;
- R5 is hydrogen, C1-4 alkyl (optionally substituted by halogen, hydroxy, C1-4 alkoxy, C3-7 cycloalkyl, SH, C1-4 alkylthio, cyano or S(O)q(C1-4 alkyl)), C3-4 alkenyl, C3-4 alkynyl or C3-7 cycloalkyl;
- R6 is phenyl, heteroaryl, phenylNH, heteroarylNH, phenyl(C1-2)alkyl, heteroaryl(C1-2 )alkyl, phenyl(C1-2 alkyl)NH or heteroaryl(C1-2 alkyl)NH;
- R7 and R8 are, independently, C1-4 alkyl;
- wherein the phenyl and heteroaryl rings of any of the foregoing are independently optionally substituted by halo, cyano, nitro, hydroxy, C1-4 alkyl, C1-4 alkoxy, S(O)mC1-4 alkyl, S(O)2NR9R10, NHS(O)2(C1-4 alkyl), NH2, NH(C1-4 alkyl), N(C1-4 alkyl)2, NHC(O)NH2, C(O)NH2, C(O)NH(C1-4 alkyl), NHC(O)(C1-4 alkyl), CO2H, CO2(C1-4 alkyl), C(O)(C1-4 alkyl), CF3, CHF2, CH2F, CH2CF3 or OCF3;
- R9 and R10 are, independently, hydrogen or C1-4 alkyl, or together with a nitrogen or oxygen atom, may join to form a 5- or 6-membered ring which is optionally substituted with C1-4 alkyl, C(O)H or C(O)(C1-4 alkyl);
- m, p and q are, independently, 0, 1 or 2;
- provided that when heterocyclyl contains a one heteroatom and that heteroatom is nitrogen, then the heterocyclyl ring is not N-linked to the remainder of the structure of formula (I);
- and provided that when R1 is cyclobutyl or tetrahydropyran, R2 is optionally substituted phenyl, R3 is hydrogen or alkoxy and R6 is benzyl (optionally substituted by alkoxy) or pyridinylmethyl, then R2a, R3a, R4, R4a and R5 are not all hydrogen;
- or a pharmaceutically acceptable salt thereof or a solvate thereof.
A compound as claimed in any one of the foregoing claims wherein R5 is ethyl, allyl or cyclopropyl.
A compound as claimed in any one of the foregoing claims wherein R6 is benzyl optionally substituted by S(O)2(C1-4)alkyl or S(O)2NR9R10;
- wherein R9 and R10 are, independently, hydrogen or C1-4 alkyl, or together with a nitrogen or oxygen atom, may join to form a 5- or 6-membered ring which is optionally substituted with C1-4 alkyl, C(O)H or C(O)(C1-4 alkyl).
Dependencies are inferred from the claim text.